| Autor: |
Toulouse JL; 1 Département de Biochimie, Université de Montréal , Québec, Canada .; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 3 PROTEO , The Québec Network for Protein Function, Structure and Engineering, Québec, Canada ., Abraham SMJ; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 3 PROTEO , The Québec Network for Protein Function, Structure and Engineering, Québec, Canada .; 4 Département de Chimie, Université de Montréal , Québec, Canada ., Kadnikova N; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 3 PROTEO , The Québec Network for Protein Function, Structure and Engineering, Québec, Canada .; 4 Département de Chimie, Université de Montréal , Québec, Canada ., Bastien D; 1 Département de Biochimie, Université de Montréal , Québec, Canada .; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 3 PROTEO , The Québec Network for Protein Function, Structure and Engineering, Québec, Canada ., Gauchot V; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 4 Département de Chimie, Université de Montréal , Québec, Canada ., Schmitzer AR; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 4 Département de Chimie, Université de Montréal , Québec, Canada ., Pelletier JN; 1 Département de Biochimie, Université de Montréal , Québec, Canada .; 2 CGCC, The Center in Green Chemistry and Catalysis , Montréal, Québec, Canada .; 3 PROTEO , The Québec Network for Protein Function, Structure and Engineering, Québec, Canada .; 4 Département de Chimie, Université de Montréal , Québec, Canada . |
| Abstrakt: |
Drug design by methods such as fragment screening requires effective solubilization of millimolar concentrations of small organic compounds while maintaining the properties of the biological target. We investigate four organic solvents and three 1-butyl-3-methylimidazolium (BMIm)-based ionic liquids (ILs) as cosolvents to establish conditions for screening two structurally unrelated dihydrofolate reductases (DHFRs) that are prime drug targets. Moderate concentrations (10%-15%) of cosolvents had little effect on inhibition of the microbial type II R67 DHFR and of human DHFR (hDHFR), while higher concentrations of organic cosolvents generally decreased activity of both DHFRs. In contrast, a specific IL conserved the activity of one DHFR, while severely reducing the activity of the other, and vice versa, illustrating the differing effect of ILs on distinct protein folds. Most of the cosolvents investigated preserved the fold of R67 DHFR and had little effect on binding of the cofactor NADPH, but reduced the productive affinity for its substrate. In contrast, cosolvents resulted in modest structural destabilization of hDHFR with little effect on productive affinity. We conclude that the organic cosolvents, methanol, dimethylformamide, and dimethylsulfoxide, offer the most balanced conditions for early-stage compound screening as they maintain sufficient biological activity of both DHFRs while allowing for compound dissolution in the millimolar range. However, IL cosolvents showed poor capacity to solubilize organic compounds at millimolar concentrations, mitigating their utility in early-stage screening. Nonetheless, ILs could provide an alternative to classical organic cosolvents when low concentrations of inhibitors are used, as when characterizing higher affinity inhibitors. |
